Algae growing as a protein source

Jessie Rack reports for NPR that demand for plant protein of all types is growing in concert with the growing interest in the U.S. to reduce meat consumption. People, from vegans to flexitarians to Meatless Monday dabblers, are substituting vegetables for meat. “(Product) developers realize we need…

BASF, Solazyme launch algal-derived betaine surfactant

BASF and Solazyme have announced the launch of the first commercial surfactant derived from microalgae oil, a high performance algal betaine for use in home and personal care applications. Commercialized by BASF under the trade name Dehyton® AO 45, algal betaine is a betaine… [Read the full story]

Algae becomes a favorite cosmetic ingredient

Jenny Muslin writes in makeitbetter.net about how, in the wake of trendy beauty product ingredients like argan oil and coconut oil, algae has joined the fray as a go-to additive that is extremely hydrating, softens and brightens skin, fights inflammation, and has loads of minerals, antioxidants…

Solazyme algal oil for Natura skincare products

Natura Cosméticos S.A. one of Latin America’s largest cosmetics and personal care products company, and Solazyme, Inc. have announced that after successfully completing testing and product validation phases over the past year using Solazyme’s tailored algal oils, Natura is… [Read the full story]

Solazyme reports Q1 2015 results

Solazyme has announced results for the first quarter ended March 31, 2015. “We are executing against our operating plan for 2015 and are pleased with the progress we are seeing across the company and in our manufacturing and commercialization efforts specifically,” said Jonathan Wolfson, CEO of Solazyme…

Flotek and Solazyme team on drilling fluid technologies

Flotek Industries, Inc. and Solazyme have entered into agreements to globally commercialize Flocapso™, an advanced drilling fluid additive. Flotek will also market Solazyme’s Encapso™ lubricant – the first commercially available, biodegradable encapsulated lubricant for drilling fluids… [Read the full story]

Solazyme reports 2014 results

Solazyme has announced that total revenue for the fourth quarter of 2014 was $14.5 million, compared with $11.3 million in the fourth quarter of 2013, an increase of 29%. Fourth quarter GAAP net loss was $44.9 million, compared to a net loss of $33.3 million in the prior year period. On a non-GAAP basis…

A look at the algae-based food landscape 2015

Nutritionaloutlook.com this month gives a well-rounded survey of how algae’s uses in food, beverage, and supplements keep expanding. Here is an excerpt: Thanks to the 2010 Solazyme Roquette Nutritionals joint venture between Roquette (Lestrem, France) and Solazyme Food Ingredients…

FDA signs off on Solazyme’s algae protein

Solazyme has received a “no questions” letter from the Food and Drug Administration on the Generally Recognized As Safe (GRAS) status of its AlgaVia whole algal protein ingredient, the San Francisco-based company said January 15. The vegan-friendly, gluten-free ingredient may be used in such applications…

A.I.M.’s 2014 Year in Review—Part 3

2014 was a year of change, a year of innovation, a year of growth. Here are some of the most encouraging developments. Most anticipated research results: The National Alliance for Advanced Biofuels and Bioproducts (NAABB) final report – it’s big and covers a lot of territory. Most interesting related technology… [Read the full story]

Solazyme tightens up use of cash

Kevin Quon writes in Seeking Alpha about the financial plights and pivots of Solazyme, the algae industry’s most high profile recent IPO. In a year that started with a share price above $11 and ended around $2.70 for the same share, Solazyme now trades with a market capitalization of just over $200 million…

Solazyme promoting new source of food protein

Most Americans get plenty of protein, primarily from animal products including meat, eggs and milk. But for many, ensuring a healthy protein intake can be challenging. In recent years a greater variety of protein-packed foods and ingredients have come to market. Joining traditional plant-based protein sources…

Solazyme partners with Versalis for Encapso

Solazyme, Inc. and Versalis, the chemical subsidiary of Eni S.p.A., one of the world’s largest oil and gas companies, today announced a partnership to expand the commercial use of Encapso – the world’s first commercially-available, biodegradable encapsulated lubricant for drilling fluids… [Read the full story]

Did Solazyme just patent an algal treatment for diabetes?

Inform Smartbrief reports that Solazyme has been issued US Patent #8,747,834 describing the use of algal biomass as a treatment for impaired glucose metabolism. Solazyme’s natural strain of algae…

Solazyme and AkzoNobel expand surfactant partnership

Solazyme and AkzoNobel, a leading global paints and coatings company and a major producer of specialty chemicals, have expanded their previously announced joint development agreement…

Solazyme Bunge Brazil plant begins commercial production

Solazyme, Inc. has announced that its joint venture with Bunge Global Innovation LLC (“Bunge”), a wholly-owned subsidiary of Bunge Limited (NYSE:BG), has successfully produced its first commercially…

Algenist Skin Care

Microalgae is at the foundation of Algenist’s clinical skincare expertise delivering anti-aging treatments to maintain youthful, beautiful skin. Solazyme’s 10 years of algal research has led to the discovery…

Unilever’s Lux soap to feature Solazyme’s algal oils

Unilever and Solazyme, Inc. have announced the initial introduction of sustainable algal oils for one of Unilever’s biggest soap brands, Lux. The decision to use algal oils is aligned with Unilever’s ambition…

Solazyme’s Algenist line launches at Nordstroms

Algenist®, Solazyme’s anti-aging skincare brand featuring microalgae, has announced its launch in Nordstrom locations throughout the United States. The launch into Nordstrom’s “Advanced Skincare”…

Solazyme raises $202.8 million in offerings

Solazyme has announced the closing of its sale of 5,750,000 shares of its common stock, and $149.5 million aggregate principal amount of 5.00% Convertible Senior Subordinated Notes due 2019…

Solazyme announces new notes and stock offering

Solazyme, Inc. has announced that it intends to offer, subject to market and other considerations, $100.0 million aggregate principal amount of convertible senior subordinated notes due 2019 (the “Notes”)…

Solazyme reports Q4 and 2013 results

Solazyme, Inc. has announced results for the fourth quarter and full year ended December 31, 2013. “2013 was a year of great progress for Solazyme as we readied our first major capacity projects…

Solazyme begins commercial production at Iowa facilities

Solazyme has announced that commercial operations have begun at both Archer Daniels Midland Company (ADM)’s Clinton, Iowa facility, and the downstream companion facility operated by American Natural…

Management changes at Solazyme

Solazyme has announced management changes to its operational leadership under CEO Jonathan Wolfson and recently-appointed President David Cole. Jean-Marc Rotsaert and the Company have mutually agreed…

Next Page »